2019 Q1 Form 10-K Financial Statement

#000121390019005149 Filed on March 29, 2019

View on sec.gov

Income Statement

Concept 2019 Q1 2018 Q4 2018
Revenue $1.735M $2.260M $8.191M
YoY Change 12.41% 9.71% 61.82%
Cost Of Revenue $1.191M $2.140M $7.648M
YoY Change -13.69% 17.58% 72.73%
Gross Profit $544.1K $120.0K $542.7K
YoY Change 232.59% -50.0% -14.37%
Gross Profit Margin 31.36% 5.31% 6.63%
Selling, General & Admin $380.4K $1.900M $3.148M
YoY Change -25.03% 45.04% 55.51%
% of Gross Profit 69.91% 1583.33% 580.04%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $3.165K $160.0K $6.764K
YoY Change 239.96% 6.67% 128.9%
% of Gross Profit 0.58% 133.33% 1.25%
Operating Expenses $1.035M $1.890M $5.389M
YoY Change 12.76% 44.27% 38.36%
Operating Profit -$490.7K -$1.770M -$4.846M
YoY Change -34.93% 65.42% 48.6%
Interest Expense $0.00 $0.00 $0.00
YoY Change -100.0%
% of Operating Profit
Other Income/Expense, Net $0.00 $2.142K
YoY Change -100.17%
Pretax Income -$490.7K -$1.780M -$4.844M
YoY Change -34.92% 66.36% 7.34%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$490.7K -$1.830M -$4.844M
YoY Change -34.92% 71.03% 7.34%
Net Earnings / Revenue -28.28% -80.97% -59.14%
Basic Earnings Per Share
Diluted Earnings Per Share -$2.333M -$8.714M -$1.136M
COMMON SHARES
Basic Shares Outstanding 4.260M shares 4.260M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2019 Q1 2018 Q4 2018
SHORT-TERM ASSETS
Cash & Short-Term Investments $250.0K $1.370M $1.370M
YoY Change -94.46% -72.04% -72.04%
Cash & Equivalents $250.5K $1.368M $1.370M
Short-Term Investments $0.00 $0.00
Other Short-Term Assets $95.80M $97.70M $990.0K
YoY Change 15106.35% 40608.33% 312.5%
Inventory $0.00 $0.00
Prepaid Expenses
Receivables $2.957M $1.746M $2.010M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $4.001M $4.362M $4.360M
YoY Change -39.11% -46.49% -46.5%
LONG-TERM ASSETS
Property, Plant & Equipment $68.17K $71.34K $70.00K
YoY Change 581.72% 949.69% 600.0%
Goodwill $4.162M $4.162M
YoY Change 0.0%
Intangibles $2.408M $2.444M
YoY Change -19.3%
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $6.638M $6.677M $6.680M
YoY Change -5.84% -7.22% -7.22%
TOTAL ASSETS
Total Short-Term Assets $4.001M $4.362M $4.360M
Total Long-Term Assets $6.638M $6.677M $6.680M
Total Assets $10.64M $11.04M $11.04M
YoY Change -21.89% -28.08% -28.08%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.250M $2.620M $2.620M
YoY Change 39.75% 21.86% 21.86%
Accrued Expenses
YoY Change
Deferred Revenue $1.580M $1.335M
YoY Change -20.21%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $3.832M $3.959M $3.960M
YoY Change 38.35% 3.61% 3.66%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $3.832M $3.959M $3.960M
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $3.830M $3.960M $3.960M
YoY Change 38.27% 3.66% 3.66%
SHAREHOLDERS EQUITY
Retained Earnings -$11.15M -$10.66M
YoY Change 83.24%
Common Stock $42.60K $2.130K
YoY Change -95.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $6.806M $7.080M $7.080M
YoY Change
Total Liabilities & Shareholders Equity $10.64M $11.04M $11.04M
YoY Change -21.89% -28.08% -28.08%

Cashflow Statement

Concept 2019 Q1 2018 Q4 2018
OPERATING ACTIVITIES
Net Income -$490.7K -$1.830M -$4.844M
YoY Change -34.92% 71.03% 7.34%
Depreciation, Depletion And Amortization $3.165K $160.0K $6.764K
YoY Change 239.96% 6.67% 128.9%
Cash From Operating Activities -$1.118M -$1.540M -$3.452M
YoY Change 190.54% 25.2% 177.93%
INVESTING ACTIVITIES
Capital Expenditures -$10.00K $71.31K
YoY Change 1601.0%
Acquisitions
YoY Change
Other Investing Activities $0.00 $10.00K $30.00K
YoY Change -100.0%
Cash From Investing Activities $0.00 -$50.20K
YoY Change 1097.4%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000
YoY Change -100.0%
NET CHANGE
Cash From Operating Activities -$1.118M -1.540M -$3.452M
Cash From Investing Activities 0.000 -$50.20K
Cash From Financing Activities 0.000
Net Change In Cash -$1.118M -1.540M -$3.502M
YoY Change 212.33% 26.23% -181.04%
FREE CASH FLOW
Cash From Operating Activities -$1.118M -$1.540M -$3.452M
Capital Expenditures -$10.00K $71.31K
Free Cash Flow -$1.118M -$1.530M -$3.524M
YoY Change 188.15% 24.39% 182.72%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2018Q1 sgbx Options Vested Description
OptionsVestedDescription
These options vest in equal installments over a two-year and three-year period and will fully vest by the end of March 31, 2021.
CY2018Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
CY2018 us-gaap Bankruptcy Proceedings Description Of Proceedings
BankruptcyProceedingsDescriptionOfProceedings
Intangible assets represent the preliminary assets identified upon emergence from bankruptcy and consist of $2,766,000 of proprietary knowledge and technology which is being amortized over 20 years and $1,113,000 of customer contracts which is being amortized over 2.5 years. In addition, included in intangible assets is $ 28,820 of trademarks and $5,300 of website which is being amortized over 5 years.
CY2017Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4260041 shares
CY2018 us-gaap Operating Loss Carryforwards Expiration Date
OperatingLossCarryforwardsExpirationDate
2037-12-31
CY2018 us-gaap Operating Cycle
OperatingCycle
The length of the Company's contracts varies, but is typically between six to twelve months.
CY2018 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2018 dei Entity Small Business
EntitySmallBusiness
true
CY2018 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2018 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2018 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2018 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2018 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2018
CY2018 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2018 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2018 dei Amendment Flag
AmendmentFlag
false
CY2018 dei Trading Symbol
TradingSymbol
SGBX
CY2018 dei Entity Central Index Key
EntityCentralIndexKey
0001023994
CY2018Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2017Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2018 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2018 dei Entity Shell Company
EntityShellCompany
false
CY2017 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
4192 USD
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
11527874 USD
CY2017 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-4512680 USD
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4870824 USD
CY2017Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2017Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
1.00
CY2018Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
1.00
CY2017Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5405010 shares
CY2018Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5405010 shares
CY2018Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2017Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
CY2017Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4260041 shares
CY2018 dei Document Type
DocumentType
10-K
CY2018 dei Document Period End Date
DocumentPeriodEndDate
2018-12-31
CY2018 dei Entity Registrant Name
EntityRegistrantName
SG BLOCKS, INC.
CY2018Q2 dei Entity Public Float
EntityPublicFloat
18446674 USD
CY2019Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
4260041 shares
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1368395 USD
CY2018Q4 us-gaap Short Term Investments
ShortTermInvestments
USD
CY2017Q4 us-gaap Short Term Investments
ShortTermInvestments
30033 USD
CY2018Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1746326 USD
CY2017Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
3005875 USD
CY2018Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
260325 USD
CY2017Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
61175 USD
CY2018Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
986687 USD
CY2017Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
183890 USD
CY2018Q4 us-gaap Assets Current
AssetsCurrent
4361733 USD
CY2017Q4 us-gaap Assets Current
AssetsCurrent
8151797 USD
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
71337 USD
CY2018Q4 us-gaap Goodwill
Goodwill
4162173 USD
CY2017Q4 us-gaap Goodwill
Goodwill
4162173 USD
CY2018Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
2443929 USD
CY2017Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
3028247 USD
CY2018Q4 us-gaap Assets
Assets
11039172 USD
CY2017Q4 us-gaap Assets
Assets
15349013 USD
CY2018Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
2624218 USD
CY2017Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
2148091 USD
CY2018Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1334887 USD
CY2017Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1673048 USD
CY2018Q4 us-gaap Liabilities Current
LiabilitiesCurrent
3959105 USD
CY2017Q4 us-gaap Liabilities Current
LiabilitiesCurrent
3821139 USD
CY2017Q4 us-gaap Preferred Stock Value
PreferredStockValue
USD
CY2017Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2018Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2017Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2018Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2018Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4260041 shares
CY2018Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4260041 shares
CY2018Q4 us-gaap Common Stock Value
CommonStockValue
42601 USD
CY2017Q4 us-gaap Common Stock Value
CommonStockValue
42601 USD
CY2018Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
17700743 USD
CY2017Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
17304529 USD
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-10663277 USD
CY2017Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-5819256 USD
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
7080067 USD
CY2018Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
11039172 USD
CY2017Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
15349013 USD
CY2018 us-gaap Revenues
Revenues
8190712 USD
CY2017 us-gaap Revenues
Revenues
5061585 USD
CY2018 us-gaap Cost Of Revenue
CostOfRevenue
7647979 USD
CY2017 us-gaap Cost Of Revenue
CostOfRevenue
4427778 USD
CY2018 us-gaap Gross Profit
GrossProfit
542733 USD
CY2017 us-gaap Gross Profit
GrossProfit
633807 USD
CY2018 us-gaap Labor And Related Expense
LaborAndRelatedExpense
2166212 USD
CY2017 us-gaap Labor And Related Expense
LaborAndRelatedExpense
1813446 USD
CY2018 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2760655 USD
CY2017 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1753236 USD
CY2018 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
387400 USD
CY2017 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
271092 USD
CY2018 us-gaap Other General Expense
OtherGeneralExpense
74629 USD
CY2017 us-gaap Other General Expense
OtherGeneralExpense
57192 USD
CY2018 us-gaap Operating Expenses
OperatingExpenses
5388896 USD
CY2017 us-gaap Operating Expenses
OperatingExpenses
3894966 USD
CY2018 us-gaap Operating Income Loss
OperatingIncomeLoss
-4846163 USD
CY2017 us-gaap Operating Income Loss
OperatingIncomeLoss
-3261159 USD
CY2018 us-gaap Investment Income Investment Expense
InvestmentIncomeInvestmentExpense
USD
CY2017 us-gaap Investment Income Investment Expense
InvestmentIncomeInvestmentExpense
330388 USD
CY2018 us-gaap Investment Income Interest
InvestmentIncomeInterest
4 USD
CY2017 us-gaap Investment Income Interest
InvestmentIncomeInterest
15 USD
CY2018 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
5764 USD
CY2017 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
1000 USD
CY2018 sgbx Loss Debt Conversion
LossDebtConversion
USD
CY2017 sgbx Loss Debt Conversion
LossDebtConversion
1018475 USD
CY2018 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
USD
CY2017 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
96327 USD
CY2018 sgbx Gain Loss From Equity Affiliaties
GainLossFromEquityAffiliaties
-3626 USD
CY2017 sgbx Gain Loss From Equity Affiliaties
GainLossFromEquityAffiliaties
USD
CY2018 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2142 USD
CY2017 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1251521 USD
CY2018 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-4844021 USD
CY2017 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
USD
CY2018 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
USD
CY2018 us-gaap Net Income Loss
NetIncomeLoss
-4844021 USD
CY2017 us-gaap Net Income Loss
NetIncomeLoss
-4512680 USD
CY2018 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.14
CY2017 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.95
CY2018 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
4260041 shares
CY2017 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
2310066 shares
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
5433295 USD
CY2017 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
701402 USD
CY2017 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
8409 USD
CY2017 sgbx Stock Issued During Period Issuance Of Convertible Preferred Stock
StockIssuedDuringPeriodIssuanceOfConvertiblePreferredStock
USD
CY2017 sgbx Stock Issued During Period Issuance Of Common Stock Net Of Issuance Costs
StockIssuedDuringPeriodIssuanceOfCommonStockNetOfIssuanceCosts
7059614 USD
CY2017 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
254500 USD
CY2017 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
2583334 USD
CY2017 us-gaap Profit Loss
ProfitLoss
-4512680 USD
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
11527874 USD
CY2018 us-gaap Profit Loss
ProfitLoss
-4844021 USD
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
7080067 USD
CY2018 us-gaap Profit Loss
ProfitLoss
-4844021 USD
CY2018 us-gaap Depreciation
Depreciation
6764 USD
CY2017 us-gaap Depreciation
Depreciation
2955 USD
CY2018 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
589619 USD
CY2017 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
587823 USD
CY2018 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
USD
CY2017 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
330388 USD
CY2018 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
810580 USD
CY2017 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
USD
CY2018 us-gaap Gain Loss On Investments
GainLossOnInvestments
4 USD
CY2017 us-gaap Gain Loss On Investments
GainLossOnInvestments
15 USD
CY2018 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
USD
CY2017 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
96327 USD
CY2018 sgbx Loss Debt Conversion
LossDebtConversion
USD
CY2017 sgbx Loss Debt Conversion
LossDebtConversion
1018475 USD
CY2018 sgbx Non Cash Consultant Fee
NonCashConsultantFee
USD
CY2017 sgbx Non Cash Consultant Fee
NonCashConsultantFee
254500 USD
CY2017 us-gaap Share Based Compensation
ShareBasedCompensation
701402 USD
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1368395 USD
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4870824 USD
CY2018 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
USD
CY2017 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
8409 USD
CY2018 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
USD
CY2017 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
7059614 USD
CY2018 us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
USD
CY2017 us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
1500000 USD
CY2018 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
USD
CY2017 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
5568023 USD
CY2018 us-gaap Share Based Compensation
ShareBasedCompensation
396214 USD
CY2018 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-3502429 USD
CY2017 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
4321724 USD
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4870824 USD
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
549100 USD
CY2018 sgbx Loss On Equity Affilaties
LossOnEquityAffilaties
3626 USD
CY2017 sgbx Loss On Equity Affilaties
LossOnEquityAffilaties
USD
CY2018 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-448969 USD
CY2017 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2771357 USD
CY2018 us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
199150 USD
CY2017 us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
27826 USD
CY2018 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
USD
CY2017 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-9445 USD
CY2018 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
802797 USD
CY2017 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
59170 USD
CY2018 us-gaap Increase Decrease In Intangible Assets Current
IncreaseDecreaseInIntangibleAssetsCurrent
USD
CY2017 us-gaap Increase Decrease In Intangible Assets Current
IncreaseDecreaseInIntangibleAssetsCurrent
28820 USD
CY2018 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
476127 USD
CY2017 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1797318 USD
CY2018 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-338161 USD
CY2017 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
1624570 USD
CY2018 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
USD
CY2017 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-72788 USD
CY2018 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3452234 USD
CY2017 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1242107 USD
CY2018 us-gaap Proceeds From Sale Of Other Investments
ProceedsFromSaleOfOtherInvestments
30037 USD
CY2017 us-gaap Proceeds From Sale Of Other Investments
ProceedsFromSaleOfOtherInvestments
USD
CY2018 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
71306 USD
CY2018 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
5300 USD
CY2017 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
USD
CY2018 us-gaap Payments To Acquire Interest In Joint Venture
PaymentsToAcquireInterestInJointVenture
3626 USD
CY2017 us-gaap Payments To Acquire Interest In Joint Venture
PaymentsToAcquireInterestInJointVenture
USD
CY2018 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-50195 USD
CY2017 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-4192 USD
CY2018 us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
USD
CY2017 us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
2583334 USD
CY2018 sgbx Conversion Of Preferred Stock To Common Stock
ConversionOfPreferredStockToCommonStock
USD
CY2017 sgbx Conversion Of Preferred Stock To Common Stock
ConversionOfPreferredStockToCommonStock
1801670 USD
CY2017Q1 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
1-for-3
CY2018Q4 us-gaap Deferred Offering Costs
DeferredOfferingCosts
1565386 USD
CY2018Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4260041 shares
CY2018Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4260041 shares
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1400000 USD
CY2018Q4 us-gaap Other Assets Current
OtherAssetsCurrent
97700000 USD
CY2018Q4 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
97657379 USD
CY2017 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
200294 USD
CY2018 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
USD
CY2017 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
USD
CY2017 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0 pure
CY2018 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0 pure
CY2018 us-gaap Use Of Estimates
UseOfEstimates
<div> <div> <p style="color: #000000; font: 10pt 'Times New Roman', Times, serif; letter-spacing: normal; orphans: 2; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; margin: 0pt 0px 0pt 0.5in;"><span style="color: black;"><b><i>Accounting estimates<span> </span></i></b>– The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States of America (“GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reporting period. Significant areas that require the Company to make estimates include revenue recognition, stock-based compensation, warrant liabilities and allowance for doubtful accounts. Actual results could differ from those estimates.</span></p> </div> </div>
CY2018 sgbx Warranty Offered On Completed Contracts
WarrantyOfferedOnCompletedContracts
P1Y
CY2018 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
8190712 USD
CY2018 sgbx Revenue From Contract With Customer Excluding Assessed Tax Percentage
RevenueFromContractWithCustomerExcludingAssessedTaxPercentage
1 pure
CY2017 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
5061585 USD
CY2017 sgbx Revenue From Contract With Customer Excluding Assessed Tax Percentage
RevenueFromContractWithCustomerExcludingAssessedTaxPercentage
1 pure
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4870824 USD
CY2017Q4 us-gaap Short Term Investments
ShortTermInvestments
30033 USD
CY2018Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
2443929 USD
CY2017Q4 us-gaap Inventory Net
InventoryNet
0 USD
CY2018Q4 us-gaap Inventory Net
InventoryNet
0 USD
CY2018 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 USD
CY2018Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1469191 USD
CY2018 us-gaap Adjustment For Amortization
AdjustmentForAmortization
589619 USD
CY2017Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
879573 USD
CY2017 us-gaap Adjustment For Amortization
AdjustmentForAmortization
587823 USD
CY2018Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
145124 USD
CY2018Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
145124 USD
CY2018Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
145124 USD
CY2018Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
140801 USD
CY2018Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
139006 USD
CY2018Q4 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
1728750 USD
CY2017Q4 us-gaap Short Term Investments
ShortTermInvestments
30033 USD
CY2017Q4 us-gaap Short Term Investments
ShortTermInvestments
30033 USD
CY2016Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
384461 USD
CY2017 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Issues
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues
USD
CY2017 sgbx Change In Fair Value Related To Conversion Of Convertible Debentures
ChangeInFairValueRelatedToConversionOfConvertibleDebentures
-288134 USD
CY2017 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Increase Decrease
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease
-96327 USD
CY2017Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
USD
CY2018 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-355765 USD
CY2017 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
2326356 USD
CY2018 sgbx Provision Income Tax Expense Benefit
ProvisionIncomeTaxExpenseBenefit
-355765 USD
CY2017 sgbx Provision Income Tax Expense Benefit
ProvisionIncomeTaxExpenseBenefit
2326356 USD
CY2018 sgbx Amount Of Valuation Reserve
AmountOfValuationReserve
-355765 USD
CY2017 sgbx Amount Of Valuation Reserve
AmountOfValuationReserve
2326356 USD
CY2018 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="margin: 0pt 0pt 0pt 36pt;"><span style="font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Concentrations of credit risk </span><span style="font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">–</span><span style="font-family: 'Times New Roman'; font-size: 10pt;"> Financial instruments, that potentially subject the Company to concentration of credit risk, consist principally of cash and cash equivalents. The Company places its cash with high credit quality institutions. At times, such amounts may be in excess of the FDIC insurance limits. The Company has not experienced any losses in such account and believes that it is not exposed to any significant credit risk on the account.</span></p> <p style="margin: 0pt 0pt 0pt 36pt; text-indent: 36pt;"><span style="font-family: 'Times New Roman'; font-size: 10pt;"> </span></p> <p style="margin: 0pt 0pt 0pt 36pt;"><span style="font-family: 'Times New Roman'; font-size: 10pt;">With respect to receivables, concentrations of credit risk are limited to a few customers in the construction industry. The Company performs ongoing credit evaluations of its customers’ financial condition and, generally, requires no collateral from its customers other than normal lien rights. At <span id="fs_V38HIYKGUO00000000000000000000FM">December 31, 2018</span> and <span id="fs_8NI7HFE94W00000000000000000000fs">2017</span>, 76% and <span style="border-left: none; border-right: none;">81</span>%, respectively, of the Company’s accounts receivable were due from two customers. </span></p> <p style="margin: 0pt; text-indent: 36pt;"><span style="font-family: 'Times New Roman'; font-size: 10pt;"> </span></p> <p style="margin: 0pt 0pt 0pt 36pt;"><span style="font-family: 'Times New Roman'; font-size: 10pt;">Revenue relating to three and two customers represented approximately 66% and 80% of the Company’s total revenue for the years ended <span id="fs_ZCNMH7FIWG00000000000000000000FM">December 31, 2018</span> and <span id="fs_79L71U547K00000000000000000000fs">2017</span>, respectively.</span></p> <p style="margin: 0pt; text-indent: 36pt;"><span style="font-family: 'Times New Roman'; font-size: 10pt;"> </span></p> <p style="margin: 0pt 0pt 0pt 36pt;"><span style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="/* background-color: #ffffff;">Cost of revenue relating to two and one </span>vendors represented approximately 55% of the Company’s total cost of revenue for the years ended <span id="fs_I3RVFXOCO000000000000000000000FM">December 31, 2018</span> and <span id="fs_J5R30FT4TS00000000000000000000fs">2017</span>, respectively. The Company believes it has access to alternative suppliers, with limited disruption to the business, should circumstances change with its existing suppliers.</span></p>
CY2018Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
2586221 USD
CY2017Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
3040110 USD
CY2018Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
839895 USD
CY2017Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
34235 USD
CY2018Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1746326 USD
CY2017Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
3005875 USD
CY2017Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
34235 USD
CY2018 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
810580 USD
CY2018 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
4920 USD
CY2017 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
0 USD
CY2018Q4 sgbx Costs Incurred On Uncompleted Contracts
CostsIncurredOnUncompletedContracts
11307975 USD
CY2017Q4 sgbx Costs Incurred On Uncompleted Contracts
CostsIncurredOnUncompletedContracts
3681965 USD
CY2018Q4 sgbx Estimated Income Loss On Uncompleted Contracts
EstimatedIncomeLossOnUncompletedContracts
-838615 USD
CY2017Q4 sgbx Estimated Income Loss On Uncompleted Contracts
EstimatedIncomeLossOnUncompletedContracts
-328273 USD
CY2018Q4 us-gaap Contract Receivable Retainage
ContractReceivableRetainage
12146590 USD
CY2017Q4 us-gaap Contract Receivable Retainage
ContractReceivableRetainage
4010238 USD
CY2018Q4 sgbx Costs In Excess Of Billings To Date
CostsInExcessOfBillingsToDate
-13221152 USD
CY2017Q4 sgbx Costs In Excess Of Billings To Date
CostsInExcessOfBillingsToDate
-5622111 USD
CY2018Q4 sgbx Contract With Customer Asset Liability
ContractWithCustomerAssetLiability
-1074562 USD
CY2017Q4 sgbx Contract With Customer Asset Liability
ContractWithCustomerAssetLiability
-1611873 USD
CY2018Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
260325 USD
CY2017Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
61175 USD
CY2018Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1334887 USD
CY2017Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1673048 USD
CY2018Q4 sgbx Contract With Customer Asset Liability
ContractWithCustomerAssetLiability
-1074562 USD
CY2017Q4 sgbx Contract With Customer Asset Liability
ContractWithCustomerAssetLiability
-1611873 USD
CY2018Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
102672 USD
CY2017Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
31367 USD
CY2018Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
31335 USD
CY2017Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
24571 USD
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
71337 USD
CY2017Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
6796 USD
CY2018 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
1937500 USD
CY2017 sgbx Fair Value Of Conversion Option Liabilities One
FairValueOfConversionOptionLiabilitiesOne
0 USD
CY2018 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
94031 USD
CY2017 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
2126062 USD
CY2018 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-449796 USD
CY2018 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210 pure
CY2017 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.340 pure
CY2018 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.074 pure
CY2017 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.074 pure
CY2018 sgbx Differences Attributable To Tax And Jobs Cut Act
DifferencesAttributableToTaxAndJobsCutAct
pure
CY2017 sgbx Differences Attributable To Tax And Jobs Cut Act
DifferencesAttributableToTaxAndJobsCutAct
-0.320 pure
CY2018 sgbx Differences Attributable To Change In State Business Apportionment
DifferencesAttributableToChangeInStateBusinessApportionment
pure
CY2017 sgbx Differences Attributable To Change In State Business Apportionment
DifferencesAttributableToChangeInStateBusinessApportionment
-0.047 pure
CY2018 sgbx Loss On Debt Conversion
LossOnDebtConversion
pure
CY2017 sgbx Loss On Debt Conversion
LossOnDebtConversion
-0.091 pure
CY2018 sgbx Prior Year Adjustment Of Taxes
PriorYearAdjustmentOfTaxes
pure
CY2017 sgbx Prior Year Adjustment Of Taxes
PriorYearAdjustmentOfTaxes
-0.471 pure
CY2018 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
pure
CY2017 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.001 pure
CY2018 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.284 pure
CY2017 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.516 pure
CY2018 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.000 pure
CY2017 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.000 pure
CY2018Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
2786519 USD
CY2017Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
3738980 USD
CY2018Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
238194 USD
CY2017Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
9709 USD
CY2018Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
364699 USD
CY2017Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
255322 USD
CY2018Q4 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
-684722 USD
CY2017Q4 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
-858811 USD
CY2017Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
2567 USD
CY2018Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
89861 USD
CY2017Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
USD
CY2018Q4 us-gaap Deferred Tax Assets Charitable Contribution Carryforwards
DeferredTaxAssetsCharitableContributionCarryforwards
233 USD
CY2017Q4 us-gaap Deferred Tax Assets Charitable Contribution Carryforwards
DeferredTaxAssetsCharitableContributionCarryforwards
234 USD
CY2018Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
2792236 USD
CY2017Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
3148001 USD
CY2018Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
2792236 USD
CY2017Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
3148001 USD
CY2018Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
USD
CY2017Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
USD
CY2018 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
-335765 USD
CY2017 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
-2326356 USD
CY2018Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
9.8 USD
CY2018Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 USD
CY2017Q4 sgbx Construction Contracts Backlog
ConstructionContractsBacklog
76659029 USD
CY2016Q4 sgbx Construction Contracts Backlog
ConstructionContractsBacklog
541291 USD
CY2018 sgbx New Contracts Received During Year
NewContractsReceivedDuringYear
29189062 USD
CY2017 sgbx New Contracts Received During Year
NewContractsReceivedDuringYear
81179323 USD
CY2018 sgbx Construction Backlog Gross
ConstructionBacklogGross
105848091 USD
CY2017 sgbx Construction Backlog Gross
ConstructionBacklogGross
81720614 USD
CY2018 sgbx Contract Revenue
ContractRevenue
8190712 USD
CY2017 sgbx Contract Revenue
ContractRevenue
5061585 USD
CY2018Q4 sgbx Construction Contracts Backlog
ConstructionContractsBacklog
97657379 USD
CY2017Q4 sgbx Construction Contracts Backlog
ConstructionContractsBacklog
76659029 USD
CY2018 sgbx Number Of Large Contracts
NumberOfLargeContracts
2 Number
CY2018Q1 sgbx Number Of Large Contracts
NumberOfLargeContracts
1 Number
CY2018 sgbx Construction Backlog Contract Revenue
ConstructionBacklogContractRevenue
55 USD
CY2017Q3 sgbx Construction Backlog Contract Revenue
ConstructionBacklogContractRevenue
15 USD
CY2018Q1 sgbx Construction Backlog Contract Revenue
ConstructionBacklogContractRevenue
25000000 USD
CY2018Q4 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
97657379 USD
CY2018Q4 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
97657379 USD
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.257 pure
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0256 pure
CY2018 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y
CY2017 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y6M
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
295051 shares
CY2016Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
1.25
CY2016Q4 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
3.00
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
250000 shares
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.28
CY2018 us-gaap Conversion Of Stock Amount Issued1
ConversionOfStockAmountIssued1
2583334 USD
CY2017 us-gaap Debt And Equity Securities Gain Loss
DebtAndEquitySecuritiesGainLoss
645833 USD
CY2017 sgbx Loss On Conversion Of Convertible Debentures
LossOnConversionOfConvertibleDebentures
1018475 USD
CY2018 us-gaap Share Based Compensation
ShareBasedCompensation
396214 USD
CY2017 us-gaap Share Based Compensation
ShareBasedCompensation
701402 USD
CY2018 us-gaap Share Based Compensation
ShareBasedCompensation
396214 USD
CY2017 us-gaap Share Based Compensation
ShareBasedCompensation
701402 USD
CY2017 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
USD
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
598552 shares
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.22
CY2017 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
4.28
CY2017 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
2803 shares
CY2017 sgbx Share Based Compensation Arrangement By Share Based Payment Award Options Exercised Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedWeightedAverageGrantDateFairValue
CY2017 sgbx Share Based Compensation Arrangement By Share Based Payment Award Options Exercised In Period Weighted Average Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedInPeriodWeightedAverageFairValue
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
2408 shares
CY2017 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue
CY2017 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
888392 shares
CY2017Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
1.23
CY2017Q4 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
3.86
CY2018 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P9Y1M24D
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
1881869 USD
CY2018 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
4.61
CY2018 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
shares
CY2018 sgbx Share Based Compensation Arrangement By Share Based Payment Award Options Exercised Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedWeightedAverageGrantDateFairValue
CY2018 sgbx Share Based Compensation Arrangement By Share Based Payment Award Options Exercised In Period Weighted Average Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedInPeriodWeightedAverageFairValue
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
33333 shares
CY2018 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue
CY2018 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1105059 shares
CY2018Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
1.24
CY2018Q4 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
4.06
CY2018 sgbx Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Remaining Contractual Term
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm
P8Y4M28D
CY2018Q4 sgbx Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value One
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValueOne
USD
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
738608 shares
CY2017Q4 sgbx Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableInPeriodWeightedAverageGrantDateFairValue
1.22
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
4.04
CY2017 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P9Y2M8D
CY2017Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
1435515 USD
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
949355 shares
CY2018Q4 sgbx Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableInPeriodWeightedAverageGrantDateFairValue
1.23
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
4.00
CY2018 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P8Y3M18D
CY2018Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
USD
CY2018 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
332662 USD
CY2017 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
701402 USD
CY2016Q4 us-gaap Stock Issued During Period Shares Restricted Stock Award Gross
StockIssuedDuringPeriodSharesRestrictedStockAwardGross
195914 shares
CY2018 sgbx Share Based Non Vested Stock Options Weighted Average Term One
ShareBasedNonVestedStockOptionsWeightedAverageTermOne
P1Y3M10D
CY2018Q4 us-gaap Share Price
SharePrice
2.71
CY2017Q1 sgbx Number Of Employees
NumberOfEmployees
3 Employee
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P2Y
CY2018Q1 sgbx Number Of Employees
NumberOfEmployees
6 Employee
CY2018Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
320000 USD
CY2018 us-gaap Payments For Legal Settlements
PaymentsForLegalSettlements
500000 USD

Files In Submission

Name View Source Status
0001213900-19-005149-index-headers.html Edgar Link pending
0001213900-19-005149-index.html Edgar Link pending
0001213900-19-005149.txt Edgar Link pending
0001213900-19-005149-xbrl.zip Edgar Link pending
ex211_1.htm Edgar Link pending
ex231_2.htm Edgar Link pending
ex311_3.htm Edgar Link pending
ex312_4.htm Edgar Link pending
ex321_5.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
sgbx-20181231.htm Edgar Link pending
sgbx-20181231.xsd Edgar Link pending
sgbx-20181231_cal.xml Edgar Link unprocessable
sgbx-20181231_def.xml Edgar Link unprocessable
sgbx-20181231_htm.xml Edgar Link completed
sgbx-20181231_lab.xml Edgar Link unprocessable
sgbx-20181231_pre.xml Edgar Link unprocessable
Show.js Edgar Link pending